Researchers have identified a protein that must be present in order for mammary stem cells to perform their normal functions. When the researchers genetically removed or chemically inhibited the protein, called BPTF, stem cells could no longer maintain their ‘renewing’ state and began to take on the character of specialized breast cells, and soon died. Breast cancer cells with stem-like properties could have the same weakness.